NCT05853887 2026-03-11
iNUDGE
Abramson Cancer Center at Penn Medicine
Phase NA Active not recruiting
Clinical Trials
12 trialsNCT07462728 2026-03-10
Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non-Oligometastatic Stage IV Non-Small Cell Lung Cancer
Guizhou Medical University
Phase NA Not yet recruiting
NCT06741085 2026-02-18
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT03133546 2026-02-06
BOOSTER
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT03977194 2025-11-18
ELDERLY
Intergroupe Francophone de Cancerologie Thoracique
Phase 3 Active not recruiting
NCT05117242 2025-11-06
Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer
Genmab
Phase 2 Active not recruiting
NCT04621188 2025-09-24
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Active not recruiting
NCT04111705 2025-04-01
ORAKLE
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Completed
NCT04951583 2024-08-07
FMT-LUMINATE
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2 Active not recruiting
NCT06378892 2024-04-23
ALK-PPL
Centro di Riferimento Oncologico - Aviano
Phase 2 Recruiting
NCT03168464 2023-04-24
Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)
Weill Medical College of Cornell University
Phase 1/2 Terminated
NCT03732482 2019-01-29
Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases
Taizhou Hospital
Phase 2/3 Unknown